Medicines360 is a nonprofit pharmaceutical organization dedicated to creating equitable access to medicines and devices for women's health. Their mission is to catalyze access through product development, policy advocacy, and global collaborations. They believe that all women, regardless of their socio-economic status, race, ethnicity, or background, deserve reliable and equitable access to medicines for their physical health and well-being.

However, current healthcare systems have failed to meet this need, resulting in various challenges and barriers to access. Medicines360 strives to address these gaps by conducting research, developing new products, and collaborating with values-driven organizations. Through their subsidiary, Curae Pharma360 Inc, they also work to improve the availability of quality generic drugs.

Their team of experts is committed to bringing effective medicines and devices to market, ensuring equitable access for women worldwide. Additionally, Medicines360 has made significant accomplishments in the United States, serving millions of women and saving millions of dollars in healthcare costs. They are also expanding their efforts globally, making their hormonal IUD, Avibela™, available in multiple countries.

By actively researching and understanding the challenges faced by women and healthcare providers, Medicines360 aims to bridge gaps in women's health and improve access to essential healthcare services